Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (31-40 of 380) with videos related to

Pageof 38
Sort By:
Haematologica|July 4, 2024
The importance of secondary cancer screening programs in Hodgkin lymphoma survivorsMarco A Salvino, Eva Domingo-Domènech, Anna Sureda
Frontiers in Neurology|April 24, 2023
CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?Roser Velasco, Alberto Mussetti, Macarena Villagrán-García, et al.
Blood Cell Therapy|May 23, 2023
The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the worldShinichiro Okamoto, Miguel-Angel Perales, Anna Sureda, et al.
The Lancet. Haematology|April 2, 2025
Celebrating 5 years of Women in Lymphoma: a road to equality, diversity, and inclusion in the fieldAnna Sureda, Astrid Pavlosky, Michelle L Poon, et al.
Blood Cell Therapy|June 10, 2024
Fostering next generation transplant physiciansShinichiro Okamoto, Miguel-Angel Perales, Anna Sureda, et al.
Cancer|June 8, 2018
Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphomaAnna Sureda, Silvia Montoto, Peter Dreger, et al.
Haematologica|July 20, 2004
Polyethylene glycol interferon-alpha2b alone or in combination with low-dose Ara-C in patients newly diagnosed with chronic myeloid leukemiaFrancisco Cervantes, Mireia Camós, Concha Boqué, et al.
Cancers|September 14, 2024
Proceedings from the First Onco Summit: LATAM Chapter, 19-20 May 2023, Rio de Janeiro, BrazilVania Hungria, Anna Sureda, Garcia Rosario Campelo, et al.
Bone Marrow Transplantation|May 26, 2018
Prevention and treatment of relapse after stem cell transplantation in lymphoid malignanciesAnna Sureda, Peter Dreger, Michael R Bishop, et al.
Bone Marrow Transplantation|April 8, 2025
Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysisAnna Sureda, Astrid Pavlovsky, Dalah Haidar, et al.
Pageof 38

Showing results (31-40 of 380) with videos related to

Sort By:
Pageof 38
Haematologica|July 4, 2024
The importance of secondary cancer screening programs in Hodgkin lymphoma survivorsMarco A Salvino, Eva Domingo-Domènech, Anna Sureda
Frontiers in Neurology|April 24, 2023
CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?Roser Velasco, Alberto Mussetti, Macarena Villagrán-García, et al.
Blood Cell Therapy|May 23, 2023
The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the worldShinichiro Okamoto, Miguel-Angel Perales, Anna Sureda, et al.
The Lancet. Haematology|April 2, 2025
Celebrating 5 years of Women in Lymphoma: a road to equality, diversity, and inclusion in the fieldAnna Sureda, Astrid Pavlosky, Michelle L Poon, et al.
Blood Cell Therapy|June 10, 2024
Fostering next generation transplant physiciansShinichiro Okamoto, Miguel-Angel Perales, Anna Sureda, et al.
Cancer|June 8, 2018
Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphomaAnna Sureda, Silvia Montoto, Peter Dreger, et al.
Haematologica|July 20, 2004
Polyethylene glycol interferon-alpha2b alone or in combination with low-dose Ara-C in patients newly diagnosed with chronic myeloid leukemiaFrancisco Cervantes, Mireia Camós, Concha Boqué, et al.
Cancers|September 14, 2024
Proceedings from the First Onco Summit: LATAM Chapter, 19-20 May 2023, Rio de Janeiro, BrazilVania Hungria, Anna Sureda, Garcia Rosario Campelo, et al.
Bone Marrow Transplantation|May 26, 2018
Prevention and treatment of relapse after stem cell transplantation in lymphoid malignanciesAnna Sureda, Peter Dreger, Michael R Bishop, et al.
Bone Marrow Transplantation|April 8, 2025
Real-world outcomes of brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in relapsed/refractory Hodgkin lymphoma: A systematic review and meta-analysisAnna Sureda, Astrid Pavlovsky, Dalah Haidar, et al.
Pageof 38